Ideaya Biosciences Inc (IDYA)

Mar 11, 2025

Ideaya Biosciences stock hits 52-week low at $17.28 By Investing.com - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

Ideaya Biosciences stock hits 52-week low at $17.28 - Investing.com

Mar 11, 2025

Mar 10, 2025

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GuruFocus.com

Mar 10, 2025

Mar 09, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up – What’s Next? - Defense World

Mar 09, 2025

Mar 05, 2025

IDEAYA Announces Further Gilead Sciences Clinical Study Collabor - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

IDEAYA Biosciences, Inc. (IDYA) Partners with ATTMOS for AI-Driven Drug Discovery Platform - Insider Monkey

Mar 05, 2025

Mar 04, 2025

Top 10 AI Trending News on Wall Street - Insider Monkey

Mar 04, 2025

Mar 03, 2025

IDEAYA Biosciences Partners With ATTMOS To Advance AI/ML-Driven Oncology Drug Discovery - Nasdaq

Mar 03, 2025

Mar 03, 2025

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accele - GuruFocus.com

Mar 03, 2025

Mar 03, 2025

Ideaya Biosciences stock hits 52-week low at $19.95 - Investing.com India

Mar 03, 2025

Mar 03, 2025

Ideaya Biosciences stock hits 52-week low at $19.95 By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

IDEAYA Biosciences, ATTMOS Collaborate to Advance Small Molecule Discovery for Undruggable Oncology Targets - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Can AI Finally Crack "Undruggable" Cancer Targets? IDEAYA's New Tech Partnership Aims to Revolutionize Oncology - StockTitan

Mar 03, 2025

Mar 03, 2025

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets - PR Newswire

Mar 03, 2025

Mar 02, 2025

Rhumbline Advisers Has $2.92 Million Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Mar 02, 2025

Mar 01, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 01, 2025

Feb 28, 2025

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Rule 5635(c)(4) - Nasdaq

Feb 28, 2025

Feb 28, 2025

IDEAYA Biosciences Grants Stock Options to 4 New Employees Under Inducement Plan - StockTitan

Feb 28, 2025

Feb 28, 2025

When the Price of (IDYA) Talks, People Listen - Stock Traders Daily

Feb 28, 2025

Feb 24, 2025

Fair Value analysis proves accurate as IDEAYA shares drop 41% in 10 months - Investing.com India

Feb 24, 2025

Feb 19, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month LowWhat's Next? - MarketBeat

Feb 19, 2025

Feb 19, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Issues Quarterly Earnings Results, Misses Expectations By $0.82 EPS - MarketBeat

Feb 19, 2025

Feb 19, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month Low – Here’s Why - Defense World

Feb 19, 2025

Feb 18, 2025

IDEAYA Biosciences, Inc. SEC 10-K Report - TradingView

Feb 18, 2025

Feb 18, 2025

Fiera Capital Corp Has $30.44 Million Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Feb 18, 2025

Feb 17, 2025

IDEAYA Biosciences' SWOT analysis: cancer therapy stock poised for pivotal year - Investing.com

Feb 17, 2025

Feb 17, 2025

How To Trade (IDYA) - Stock Traders Daily

Feb 17, 2025

Feb 17, 2025

IDEAYA announces proposed public offering of common stock and pre-funded warrants - MSN

Feb 17, 2025

Feb 16, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Trading Down 4.8%Time to Sell? - MarketBeat

Feb 16, 2025

Feb 15, 2025

IDEAYA Biosciences Stock Gains Momentum as Analysts Reaffirm Bullish Outlook - HPBL

Feb 15, 2025

Feb 15, 2025

IDEAYA Biosciences' (IDYA) "Overweight" Rating Reiterated at Stephens - MarketBeat

Feb 15, 2025

Feb 15, 2025

Down -8.63% in 4 Weeks, Here's Why You Should You Buy the Dip in IDEAYA Biosciences (IDYA) - MSN

Feb 15, 2025

Feb 15, 2025

IDEAYA Biosciences (IDYA) Expected to Announce Earnings on Tuesday - MarketBeat

Feb 15, 2025

Feb 14, 2025

IDEAYA Biosciences Reports 2024 Financials and Business Update - TipRanks

Feb 14, 2025

Feb 14, 2025

WCM Investment Management LLC Buys Shares of 241,894 IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Feb 14, 2025

Feb 13, 2025

Ideaya Biosciences stock hits 52-week low at $21.02 By Investing.com - Investing.com Australia

Feb 13, 2025

Feb 13, 2025

Q1 Earnings Estimate for IDYA Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025

Feb 13, 2025

IDEAYA BIOSCIENCES Earnings Results: $IDYA Reports Quarterly Earnings - Nasdaq

Feb 13, 2025

Feb 13, 2025

IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss - MSN

Feb 13, 2025

Feb 13, 2025

Ideaya Biosciences falls as quarterly loss widens - TradingView

Feb 13, 2025

Feb 13, 2025

IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

IDEAYA announces expanded collaboration with Gilead Sciences - MSN

Feb 13, 2025

Feb 13, 2025

Ideaya Biosciences enters additional supply pact with Gilead for IDE397 - TipRanks

Feb 13, 2025

Feb 13, 2025

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule - Fierce Biotech

Feb 13, 2025

Feb 13, 2025

IDEAYA Biosciences Q4 Loss Widens, Revenue Rises -February 13, 2025 at 06:59 am EST - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q4 Collaboration Revenue of $7M - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

IDEAYA Q4 Earnings: Massive $1.1B War Chest Fuels Breakthrough Cancer Drug Development - StockTitan

Feb 13, 2025

Feb 13, 2025

IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy® and IDE397 in MTAP-Deletion NSCLC - Nasdaq

Feb 13, 2025

Feb 13, 2025

Ideaya Biosciences stock hits 52-week low at $21.02 - MSN

Feb 13, 2025

Feb 12, 2025

abrdn plc Has $7.88 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Feb 12, 2025